BACKGROUND AND AIMS: The standard diagnostic tool for acute hepatitis A is detection of anti-hepatitis A virus (HAV) immunoglobulin M (IgM). However, a negative result for anti-HAV IgM can be obtained in the early phase of infection. Among clinically suspicious seronegative patients, diagnosis of hepatitis A is sometimes recorded on retesting. PATIENTS AND METHODS: This study included patients who had attended the Kyung Hee University East-West Neo Medical Center from November 2006 to October 2008. We evaluated 27 patients (15 men, 12 women) who had undergone repeated anti-HAV IgM testing. RESULTS: Thirteen patients were diagnosed with hepatitis A after retesting, and 14 with non-hepatitis A (non-HA). High initial cutoff index (COI) for anti-HAV IgM (≥0.5), low serum total bilirubin (<1.4 mg/dl), and low platelet count (<165 × 10(3)/μl) were related to a positive result for anti-HAV IgM retesting, although this association was not statistically significant on multivariate analysis. In the HA group, 7 of 13 patients had an initial COI for anti-HAV IgM of >0.5 compared with none of 14 patients in the non-HA group. CONCLUSIONS: Initial COI for anti-HAV IgM, serum total bilirubin, and platelet count were helpful for predicting positive results for retesting among initially seronegative patients.
BACKGROUND AND AIMS: The standard diagnostic tool for acute hepatitis A is detection of anti-hepatitis A virus (HAV) immunoglobulin M (IgM). However, a negative result for anti-HAV IgM can be obtained in the early phase of infection. Among clinically suspicious seronegative patients, diagnosis of hepatitis A is sometimes recorded on retesting. PATIENTS AND METHODS: This study included patients who had attended the Kyung Hee University East-West Neo Medical Center from November 2006 to October 2008. We evaluated 27 patients (15 men, 12 women) who had undergone repeated anti-HAV IgM testing. RESULTS: Thirteen patients were diagnosed with hepatitis A after retesting, and 14 with non-hepatitis A (non-HA). High initial cutoff index (COI) for anti-HAV IgM (≥0.5), low serum total bilirubin (<1.4 mg/dl), and low platelet count (<165 × 10(3)/μl) were related to a positive result for anti-HAV IgM retesting, although this association was not statistically significant on multivariate analysis. In the HA group, 7 of 13 patients had an initial COI for anti-HAV IgM of >0.5 compared with none of 14 patients in the non-HA group. CONCLUSIONS: Initial COI for anti-HAV IgM, serum total bilirubin, and platelet count were helpful for predicting positive results for retesting among initially seronegative patients.
Authors: O S Kwon; K S Byun; J E Yeon; S H Park; J S Kim; J H Kim; Y T Bak; J H Kim; C H Lee Journal: J Gastroenterol Hepatol Date: 2000-09 Impact factor: 4.029
Authors: Eung Jun Lee; So Young Kwon; Tae Ho Seo; Hyun Sung Yun; Han Su Cho; Byung Kook Kim; Won Hyeok Choe; Chang Hong Lee; Jin Nam Kim; Hyung Joon Yim Journal: Korean J Gastroenterol Date: 2008-11
Authors: Hyung Min Kang; Sook Hyang Jeong; Jin Wook Kim; Donhun Lee; Chang Kyu Choi; Young Soo Park; Jin Hyuk Hwang; Nayoung Kim; Dong Ho Lee Journal: Korean J Hepatol Date: 2007-12
Authors: B H Robertson; R W Jansen; B Khanna; A Totsuka; O V Nainan; G Siegl; A Widell; H S Margolis; S Isomura; K Ito Journal: J Gen Virol Date: 1992-06 Impact factor: 3.891
Authors: Jong Jin Hyun; Yeon Seok Seo; Hyonggin An; Sun Young Yim; Min Ho Seo; Hye Sook Kim; Chang Ha Kim; Ji Hoon Kim; Bora Keum; Yong Sik Kim; Hyung Joon Yim; Hong Sik Lee; Soon Ho Um; Chang Duck Kim; Ho Sang Ryu Journal: Korean J Hepatol Date: 2012-03-22